Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials

Completed

Conditions studied: Respiratory Distress Syndrome, Adult

In brief

Acute lung injury (ALI) is a severe lung condition that causes respiratory failure. The ARDS Network (ARDSNet) is a National Heart, Lung, and Blood Institute-sponsored network that is focused on improving treatments for people with ALI and a similar condition called acute respiratory distress syndrome (ARDS). This study will evaluate participants who were enrolled in one of three ARDSNet studies to examine how the treatments carried out in the prior studies affect participants' long-term health outcomes and quality of life.

Key facts

Study ID

NCT00719446

Run by

Johns Hopkins University

People needed

922

Starts

2007-10-01

Expected to finish

2014-10-01

Last updated by the study team

2015-09-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participated in the ALTA, EDEN, OMEGA, or SAILS study
• Survived until hospital discharge

You may not qualify if…

• Does not understand or speak English
• Has no fixed address
• Pre-existing cognitive impairment that prevents completion of the study assessments

Where it is running

• University of Maryland Medical Center — Baltimore, Maryland, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Wake Forest University — Winston-Salem, North Carolina, United States
• Vanderbilt University — Nashville, Tennessee, United States
• Intermountain Medical Center — Murray, Utah, United States
• University of Washington/Harborview Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.